ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

Judge Clears Way For Trial Pitting FDA Against Physicians Over First Amendment

March 24, 1995

Gallo Publishes Study to Resolve controversy Over HIV Discovery

March 15, 1991

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985